Could Prenatal Tylenol Use Affect Autism Spectrum Disorder?

assorted painkillers

Is there such a thing as a completely safe form of medicine? The short answer is no. Even if a medication seems innocuous, every medicine can potentially produce side effects, especially when a patient is experiencing a major health event like a pregnancy. The hope is that that the potential benefits of the medicine outweigh the negatives. Recent medical research, however, has indicated that one of the most common medicines taken during pregnancy could produce a number of harmful side effects to the children, which may make doctors change how they treat women during pregnancy.

According to findings published in a study for the International Journal of Epidemiology, the study found that use of paracetamol, otherwise known as acetaminophen with the most famous brand name being Tylenol, caused some concern as researchers found that there was a thirty percent increased risk of a child being diagnosed with autism spectrum disorder. The study included 2644 mother and child pairs, and it indicated that males may be more likely to be affected by the use of paracetamol. Here is what one of the co-authors of the study said:

“Paracetamol could be harmful to neurodevelopment for several reasons. First of all, it relieves pain by acting on cannabinoid receptors in the brain. Since these receptors normally help determine how neurons mature and connect with one another, paracetamol could alter these important processes. It can also affect the development of the immune system, or be directly toxic to some fetuses that may not have the same capacity as an adult to metabolize this drug, or by creating oxidative stress.”

So in regard to medication and how it can influence possible symptoms of autism spectrum disorder, one might have to wonder how medicine may also influence potential chronic conditions. CMRSI has made it a point to study risk factors for developing chronic conditions and whether common preventative measures like vaccines could influence increases in autism spectrum disorder diagnoses. The combined risk of multiple vaccines given during pregnancy and early in life while taking such common medications such as acetaminophen is currently unknown, and should be a priority for researchers looking to unravel the causal factors underlying the autism and chronic illness epidemics.

CMSRI is seeking funding from the public and from foundations and philanthropists to conduct studies important to child health and well-being. Please visit to help expedite the answers parents need to protect their children’s health.


Patients With Autoimmune Diseases Ask: What is “ASIA”?

The 9th International Congress on Autoimmunity, which included 3,000 doctors and scientists from around the world, commenced in 2014 to discuss one of the most intriguing and important items in the field of autoimmunity: the discovery of a new post-vaccine disorder associated with vaccine aluminum adjuvants called “Autoimmunity/Inflammatory Syndrome Induced by Adjuvants,” also known as ASIA.

Scientists and organizations like the Children’s Medical Safety Research Institute have long explored autoimmunity and the relationship between aluminum adjuvants in vaccines and adverse autoimmune responses. Aluminum is a known neurotoxin to all organisms, and a breadth of scientific research has demonstrated that aluminum plays a significant role in the development of dementia, autism, and Parkinson’s disease. Aluminum exposure has also been linked to cancer and Alzheimer’s disease, among other adverse health conditions.

Defining ASIA

ASIA is therefore only the latest autoimmune syndrome in a long list of disorders associated with aluminum adjuvants.

ASIA was first discovered in 2011 by Yehuda Shoenfeld, who characterizes the disorder as encompassing a wide range of symptoms, including weakness, anxiety, rashes, fatigue, sleep disorders, and arthritis, just to name a few. The disorder also refers to any environmental factor demonstrated to trigger autoimmune conditions. This means that aluminum adjuvants are just one of the many environmental factors that can be associated with ASIA. Squalene, a chemical component of vaccines used on Gulf War military members is also linked to autoimmune disorders that fall under the ASIA criteria. ASIA symptoms can manifest within week or years of an aluminum-adjuvant containing vaccine injection.

At the 9th International Autoimmunity Congress, the ASIA Syndrome was the subject of several presentations, including one by Dr. Carlo Perricone. He was among four presenters voted by his peers to present in a final Plenary Session. Interest in Dr. Perricone’s talk and the ASIA Syndrome highlighted the concern among scientists that autoimmune diseases are rapidly increasing, there are few effective treatments, diagnosis has become more difficult due to diverse symptoms, and there is a great need for more research to understand instigators and treatment options to help a rising tide of sick patients. His talk based on his research, “Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects, underscored the need to understand how vaccine adjuvants are contributing to such serious adverse events such as narcolepsy that was linked to a new adjuvant in some flu vaccines.

The International ASIA Registry

The 9th International Congress on Autoimmunity announced that an official international ASIA registry would be established, and this registry officially opened in January of 2015. The registry is currently being used as a tool to analyze the nature and prevalence of autoimmune diseases throughout the world; with this data, researchers hope to learn more about the specific causes of autoimmunity. Currently, approximately 70% of registered cases followed administration of the Hepatitis B vaccination.

Animal studies have also demonstrated similar adverse autoimmune conditions upon overexposure to aluminum, such as general weakness and muscular atrophy in sheep. Research conducted by leading adjuvant researcher Christopher Shaw found that mice injected with aluminum at levels corresponding to what’s found in vaccines displayed social interaction deficits and elevated anxiety levels.

Find more information about the ASIA Registry and learn how to submit a case study here.


Neurodevelopmental Toxicity of Aluminum Compounds

How much do we know about aluminum? It has been used in various applications for the past 90 years, which would lead one to assume that it’s a safe and effective compound. However, this assumption has very little research backing its ‘beneficial’ use and quite a significant body of research describing its toxic effects on the brain and immune system. Parents, doctors and scientists are asking why it continues to be formulated in things like vaccines, infant formula and other ingestible sources?

Two researchers from Children’s Medical Safety Research Institute took a look at various aluminum sources and their adverse effects in an animal model and in humans.  The purpose of their study was to evaluate the effects of pediatric vaccine relevant quantities of aluminum adjuvants on cognitive, motor and behavioral function, as well as to evaluate biological and genetic changes that take place after injected exposures to aluminum adjuvants. By comparing the outcomes of the exposed mice to a control group that received a true inert saline placebo, the effects of aluminum in the vaccine schedule could be isolated and quantified. This study has provided significant evidence that aluminum is more harmful than the public has perceived it to be, and it is clear that aluminum is a dangerous neurotoxin.

In the research, Dr. Christopher Shaw and Dr. Lucia Tomljenovic studied a number of aluminum sources/compounds and how they affected the individual or animal that was exposed. In the chart of data they compiled, they noted the amount of aluminum found in standard infant feeding solution where premature infants were exposed to about ~20 μg/kg a day. The aluminum-formulated solution resulted in a reduced developmental attainment at the post-term age of 18 months compared to infants who were fed with aluminum-depleted solutions. This significant neurodevelopmental change is one of the many data sets found in the chart that compares the effects of non-aluminum compounds to aluminum-sourced compounds.

To support their findings, human exposure data included symptom changes for patients suffering from renal/kidney failure. These patients were exposed to to aluminum-tainted dialysis fluid while being treated for their condition. However, they discovered that the dialysis fluid actually made their symptoms much worse. Some of the noted symptoms after the aluminum-tainted dialysis fluid treatment began included:

  • Impaired concentration
  • Behavior changes
  • Epileptic seizures
  • Coma
  • Memory loss
  • Speech problems
  • And more

These symptoms were not present before the dialysis began and interestingly enough, the patients who suffered from these side effects took a turn for the better when aluminum was removed from the dialysis fluid. This key example is strong evidence that the aluminum-tainted dialysis fluid was the culprit behind the symptoms, yet the use of aluminum continues. Additionally, the researchers point out that aluminum has a great potential to act as a toxic co-factor in the onset of many neurodegenerative diseases like autism, Alzheimer’s, Parkinson’s and other conditions. With the large amount of scientific research outlining the adverse effects of aluminum, the compound should be given more scrutiny and oversight as its presence in medicines, vaccines and consumer products has increased significantly over the last three decades. As aluminum’s increased use has coincided with an increased rate of chronic illness and disability, and there is ample scientific evidence linking aluminum to immune and neurotoxicity, reconsidering its approval in products that humans use or consume could reduce the frequency of chronic illness cases.

Understanding the Autism Spectrum Disorder

Do you know an individual with Autism Spectrum Disorder? That your answer to this question is “yes” is more probable than it’s ever been before. Today, 1 in every 68 children in the U.S. will be born with ASD, an astonishing ratio considering that less than fifty years ago, just 4 in 10,000 children were born with this disorder. Since the 1980s, ASD has affected an exponentially larger number of children with each passing decade, and though the cause of ASD has yet to be determined, it’s important to continue to raise awareness and enhance our understanding of this disorder, as do organizations like the Children’s Medical Safety Research Institute.

So what should you know about ASD?

ASD is a neurodevelopmental disorder that affects both boys and girls of every ethnicity, though research has shown that boys have a higher likelihood of developing autism than girls. Individuals with this disorder are considered to be on a spectrum, because this disorder’s severity and the way in which it manifests can vary significantly. Unlike other disorders, ASD is not defined by a readily identifiable set of symptoms that are largely uniform across an affected population.

However, there are social, behavioral, and language impairments that are common among individuals on the spectrum. These include, but are not limited to:

  • Difficult making eye contact
  • Difficulty understanding facial cues
  • Delayed language development
  • Difficulty sustaining a conversation
  • Social and emotional distance
  • Repetitive phrases and movements
  • Unique ways of communicating needs

Children with ASD typically begin showing symptoms between 12 and 18 months, which makes identifying ASD in infants challenging. Detecting ASD early is advantageous because research suggests that the sooner children receive intervention, the greater their potential for improved symptoms. There is no cure for ASD, which means that ASD symptoms can remain with a child for the entirety of his or her life. This makes effective intervention even more imperative; though an individual may always have ASD, with intervention, he or she may be able to live life in a more functional, independent capacity.

Naturally, parents are often the first to notice that their young child does not show signs of normal social, linguistic, and behavioral development. However, it’s also important to emphasize that parents are typically the only ones who know their child well enough to make such an early judgment; parents should therefore be diligent in their efforts to monitor development and immediately seek a professional opinion when suspicions arise.

Given that 3.5 million individuals live with ASD in the U.S. today, we have a responsibility to invest our time and effort into learning more about this disorder, including its causes and possible treatments.



Scientific Organizations Join Together for Autism Research

April is always a month of hope for the autism community, as April is Autism Awareness Month. During this time, the U.S. raises recognition, support, and funding for one of the most prevalent neurodevelopmental disorders affecting young children today. This year, amid the nation’s ongoing fundraisers, events, and social media campaigns, organizations devoted to autism research will come together at the AutismOne Cutting-Edge Autism Conference,® to be held in Chicago. The annual conference, which attracts over one thousand international guests and dozens of leading presenters, will feature the research of scientific organizations like Focus for Health as well as the Children’s Medical Safety Research Institute. The Children’s Medical Safety Research Institute focuses on discovering causal factors underlying a range of chronic illnesses affecting children, including autism.

Specifically, at the AutismOne Cutting-Edge Autism Conference® this year, the Children’s Medical Safety Research Institute will speak on their landmark research involving aluminum and HPV vaccines in a presentation entitled, “Aluminum Toxicity Track and the HPV Vaccine Safety Track.” CMSRI has communicated research findings about aluminum’s toxicity to both children and adults, and has focused much of their research on the adverse effects of exposure via vaccine aluminum adjuvants. CMSRI has most recently raised awareness about new HPV vaccines, which are administered in multiple doses and contain alarmingly twice as much aluminum adjuvants as previous HPV vaccines.  Despite the significant amount of research that has been collected on the dangers of aluminum adjuvants, the FDA has yet to take any steps towards reducing aluminum concentrations in commonly-administered childhood vaccines, and as evident from the latest HPV vaccine, is even willing to let pharmaceutical companies increase aluminum adjuvant concentrations despite there being no evidence of safety.

The adverse effects of aluminum adjuvants first gained widespread attention after Drs. Christopher Shaw and Lucija Tomljenovic published their groundbreaking paper, “Etiology of Autism Spectrum Disorders: Genes, Environment, or Both?” which concluded that while there may be genetic factors at play in the etiology of autism, there is credible evidence to strongly suggest that environmental factors like vaccine aluminum adjuvants are also influencing a child’s risk for developing autism.

The Children’s Medical Safety Research Institute also recently hosted the 3rd International Symposium on Vaccines at the end of March. The symposium featured 15 presentations concerning autoimmune diseases and the role of adjuvants in vaccines; presenters of diverse scientific concentrations, such as neuroscience, genetics, and immunology, were all in attendance to discuss their research

Through conferences, symposiums, and continued research, organizations like the Children’s Medical Safety Research Institute are striving to make meaningful progress towards discovering causes for the autism epidemic. Given that the government has been less than receptive to research on these topics, it seems that only with the persistent voices of these independent research organizations will progress ever be made.


Examining Increases in Aluminum Adjuvant Exposure

Though aluminum is scientifically proven to be detrimental to human health, aluminum’s toxicity has largely been understated or outright ignored, even by agencies tasked with protecting the public’s health. These organizations, like the CDC and FDA, are well-aware of research published on the toxic properties of aluminum; yet, aluminum adjuvants are not only present in many vaccines, but are increasing in concentration.

The latest release of the Gardasil HPV vaccine, Gardasil 9, is one example of increasing quantities of aluminum adjuvants. Gardasil 9, which has been engineered to protect against 9 different types of HPV, now contains more than twice the amount of aluminum adjuvant as Gardasil’s original version. Even Gardasil manufacturer Merck’s own study of its original version revealed alarming statistics about serious adverse effects of the vaccine, including disabilities and precancerous lesions, while independent research has identified more than 22,000 adverse effects associated with the Gardasil vaccine. Gardasil 9 contains 500 mg of aluminum adjuvant, while Gardasil contains just 225 mg; considering Gardasil 9 is administered in 3 doses over the course of 3 years, this means that recipients will intramuscularly receive 1500 mg of aluminum throughout their Gardasil 9 administration.

Gardasil 9 was also approved by the FDA without a review from the Vaccines and Related Biological Products Advisory Committee, a committee specifically tasked with assessing potential risk factors of vaccines that are up for FDA approval. In its letter of explanation, the FDA stated that Gardasil 9 did not present the type of controversy or concern that would merit a review from the VRBPAC. However, it’s only up to the VRBPAC itself to determine if any concerns exist. Forbes has already reported that a study of Gardasil 9 involving 13,000 recipients resulted in 305 reports of serious adverse effects.

Research supported by the Children’s Safety Medical Research Institute has also revealed that the Gardasil vaccine is 2.5 times more likely to cause a serious adverse effect than cervical cancer, the threat Gardasil is intended to protect against.

Aluminum adjuvants remain present in a wide range of routinely administered vaccines, including tetanus, diphtheria, hepatitis, and pertussis vaccines; because no official threshold has been established for safe quantities of aluminum exposure, no plans are in the works to reduce these current concentrations of aluminum adjuvants.  As researcher Christopher Exley points out in his paper, “Human Exposure to Aluminum,” in 1950 Americans were exposed to approximately 1 mg of aluminum per day. By 2050, it’s projected that our level of daily exposure will increase to 100 mg.

Direct links have also recently been demonstrated between aluminum and Alzheimer’s disease, a neurological disease which, like autism, has been rapidly increasing in recent decades. In 2010 there were 500,000 new cases of Alzheimer’s, and this number is increasing each year. By 2050, it’s expected there will be 1 million new cases of Alzheimer’s each year. While some cases of Alzheimer’s result from genetic dispositions, its rapidly increasing rates are best explained by exposures to toxic environmental elements, like aluminum, which we are exposed to in increasing amounts and via more diverse avenues.

Unfortunately, there’s little question that our exposure to aluminum is increasing, and that little is being done to reduce it. It seems it will be up to researchers and a conscientious public to begin to change views about this highly toxic element.



Is There a Vaccine Debate Occurring? It Doesn’t Seem Like It.

When analyzing coverage of the recently reignited vaccine debate, it seems as though there’s not much of a debate occurring at all. Rather, media outlets and commentators have quickly dismissed those that maintain doubts about the safety of vaccines as illogical or misinformed, without understanding the reasoning behind their views.  This imbalanced coverage should strike those on both sides of the issue as highly problematic. If scientific understanding is to truly advance, the voices and concerns of minority groups shouldn’t be overtly marginalized or suppressed, especially in light of an abundance of credible supporting evidence.

In the last three decades, extensive research has been conducted by multiple scientists and organizations that demonstrate links between vaccine administration and a risk of chronic illness, disability, and neurodevelopmental disorders. These researchers comprise a group of highly-qualified and experienced scientists from around the world. In 2013, Canadian scientists Dr. Lucija Tomljenovi and Christopher Shaw found that the aluminum adjuvants in childhood vaccines increase a recipient’s risk for developing autism, neurological problems, and autoimmune diseases. In addition to aluminum adjuvants, many vaccines include a number of other toxic elements, including Thimerosal, polysorbate 80 and formaldehyde, to name a few. Dozens of independent research articles have been published on the negative effects of these ingredients, yet the CDC has only relied on a handful of studies, many of which have been identified as maintaining methodological flaws, to support its stance that vaccines pose no threats to recipients.

Immunologists like Dr. J Barthelow Classen have also identified links between vaccines and chronic illnesses like obesity, autism, and diabetes, all of which have increased dramatically among children in recent years. Numerous studies about the adverse health effects of the Gardasil vaccine, flu vaccine, and hepatitis vaccine also provide extensive insight into the potential dangers of vaccination.

There are also a number of prominent health professionals that have made statements in support of the anti-vaccination movement, yet these officials are rarely included in mainstream discussions of vaccination. For example, the former head of the National Institutes of Health, the Red Cross, and the Chair of the White House Cabinet Group on Biotechnology has spoken out against the dismissal of research that suggests a link between vaccines and chronic illness, noting that the research does raise legitimate doubts about vaccine safety.  Even Dr. Diane Harper, a developer of the Gardasil HPV vaccine, has stated she now believes the vaccine has the potential to be harmful to recipients. Prominent researchers and faculty from a number of academic and research institutions like the Children’s Medical Safety Research Institute have made public their concerns about vaccine safety, yet these voices are not the ones the media , nor the government, has acknowledged.

We may also note that pharmaceutical companies and government health organizations have more to gain from asserting that vaccines are safe than those who question vaccine safety do. Widespread vaccination translates into substantial profits for pharmaceutical companies, while those that question the safety of vaccines have nothing to gain, other than safer vaccinations for their children.

Ultimately, a real debate about vaccine safety, one in which evidence from both sides is presented, will pave the way for more productive discussion and a better understanding of the potential risks of vaccination.


How Do Aluminum Adjuvants Work?

Over the years the chemical compound of aluminum, has been used in a wide variety of vaccines to act as stimulant when injected into the human body. It should be noted, that aluminum is a non-essential metal when it comes to human function. That is why Dr. Christopher Exley, a funded researcher at the Children’s Medical Safety Research Institute, has written an article to raise awareness of aluminum adjuvants.

It goes without saying that many people do not know of all the ingredients used in vaccinations or what they actually do, which is why, knowledge on such a topic is vital to the safety of patients.

Often, doctors will tell patients very little about the possible side effects of vaccines because even they do not really know what could happen. Did you know vaccine manufactures are protected by trade secrets and they don’t have to reveal all the ingredients in a vaccine? This means your trusted doctor may not have all the answers to your questions or even know what he is about to inject into your body. Situations like this, can make patients wary of getting even the flu shot.

Aluminum adjuvants are used to excite the immune system when injected in a vaccine, this is so that your body can react to the injection. However, aluminum adjuvants have been linked to various adverse reactions. which raises the question: why are they still being used?

In Exley’s article “The immunobiology of aluminum adjuvants: how do they really work,” he identifies ‘the many ways that aluminum chemistry contributes to the wide and versatile armory of its adjuvants, such that future research might be guided towards a fuller understanding of their role in human vaccinations.’ In laymen terms, the use of aluminum adjuvants have yet to undergo intense clinical studies and continued use of them could pose serious health risks. Understanding the neurotoxicity of the aluminum adjuvants, is the key issue at hand because numerous studies and cases have noted many ill-effects using this added ingredient.

Until recently, the lack of research regarding aluminum was alarming; however, current efforts, may raise awareness of adverse reactions, which can help guide clinicians and chemical engineers to revise these practices in manufactured vaccines.

Just like the many disclaimers we read about on drugs, the user may experience specific reactions, ‘as individuals, will not all respond in an identical manner, either in the short or long term, to injection of aluminum into our tissue.’

Three Women Suffer from Primary Ovarian Failure Following HPV Vaccination

Funded CMSRI researchers conducted a study, after three women developed secondary amenorrhea and primary ovarian failure following HPV vaccinations. Lucija Tomljenovic and Yehuda Shoenfeld found links to the development of their conditions and the adjuvants found in HPV vaccinations.

The researchers partnered with Serena Colafrancesco and Carlo Perricone to fully investigate the issue. All three women suffered from secondary amenorrhea, which is the absence of a menstrual cycle.

Their problem was not resolved using hormone replacement therapies. The researchers found auto-immune antibodies in two of the patients, anti-ovarian and anti-thyroid respectively, suggesting that the HPV vaccine triggered an autoimmune response. However, all three patients experienced common post-vaccination symptoms including:

  • Nausea
  • Headache
  • Sleep disturbances
  • Arthralgia
  • A range of cognitive and psychiatric disturbances

The researchers concluded that evidence of adjuvants in the HPV vaccine could trigger a life-disabling autoimmune condition, as they saw with the amenorrhea.

In recent news, a new syndrome, called autoimmune/inflammatory syndrome induced by adjuvants (ASIA), or Shoenfeld’s syndrome, has been making its way into the medical field.

ASIA involves immune-mediated conditions that appear following a chronic stimulation of the immune system, by agents with adjuvant characteristics.

The post-vaccination autoimmune responses are a major concern regarding ASIA. HPV vaccines and others are known for their use of aluminum adjuvants, which are neurotoxins. These adjuvants are creating correlations between adverse reactions, as these cases suggest. Two of the patients who were studied were sisters who both developed primary ovarian failure. The sisters, 13 years old and 14 years old, received three HPV vaccinations with worsening side effects, including irregular periods, thereafter, resulting in a total absence of their menstrual cycles.

The third woman began the administration of the HPV vaccine at the age of 21 and developed irregular menstrual cycles. The patient underwent therapy, but by the age of 23, she suffered from amenorrhea and Medroxy-progesterone. Estradiol therapy was attempted but it did not improve her clinical condition.

Tomljenovic and Shoenfeld ruled out all other possible causes for the three patients diagnosed with primary ovarian failure (POF). They concluded that the HPV vaccination was the root of the adverse reactions because the patients were all clinically healthy before they were vaccinated.

Among the startling statistics regarding POF, it only affects one percent of women under 40 years old and 0.01 percent of women under the age of 20. It is an important cause of infertility and psychological stress. The results can have significant consequences for these women’s future health and their prospects of motherhood. The origins of POF have been widely debated and the evidence found in this case strongly supports its association with toxic adjuvants entering the body and negatively manipulating autoimmune responses.

Drastic Increase of Autism Reported

Autism spectrum disorder (ASD) has a prevalence of 1 in 68 children – a 30% increase since 2012 according to the Center for Disease Control and Prevention (CDC). ASD was once a rare disorder but is occurring more frequently than before, as more cases are being diagnosed each year. The reason for this increase may be linked to certain ingredients found in vaccines, specifically aluminum formulated vaccines. Dr. Stephanie Seneff, a funded CMSRI researcher, has reviewed empirical data that confirms autism symptoms related to aluminum and acetaminophen exposure.

Autism and ASD can be defined as a condition characterized by impaired cognitive and social skills along with compromised immune function. The fact that ASD rates have rapidly increased over the last two decades suggests that there are environmental components that lead to its prevalence. The root cause of ASD is still unknown; however, current research is suggesting that the use of vaccines are playing a role in its development. In her review titled Empirical Data Confirm Autism Symptoms Related to

Aluminum and Acetaminophen Exposure, Dr. Seneff points out the word frequency patters in the CDCs Vaccine Adverse Events Reporting System (VAERS) database.

The VAERS is a database executed by the U.S. government that allows doctors and patients to report any adverse reactions noted in association with vaccines. After conducting a search of the words “autism” and “autistic,” Dr. Seneff plotted the word frequencies based on year and could visually graph spikes in adverse reactions with vaccines and the aforementioned keyword.


“The incidence of autism-related adverse events in the VAERS database continued to rise over the time period after the amount of thimerosal in the vaccines had been sharply reduced. We hypothesize that this unanticipated consequence is due to simultaneous increases in the aluminum content, attributed to an increased number of required vaccines, intentional addition of aluminum to achieve an adjuvant effect, as well as the likely further accumulation of aluminum as a consequence of leaching, given the new practice of storage in individual glass vials with rubber stoppers. We identified several severe adverse reactions that were much more prevalent in reports from the second decade of the data, and showed that these same symptoms were also much more prevalent for reports involving aluminum-containing vaccines compared to reports on vaccines without aluminum, over the entire data set. These symptoms include seizure, cyanosis, gaze palsy, depression, fatigue, insomnia, and death.”

With the above database available from the CDC, researchers can find specific trends relating aluminum to autism by the noted adverse reactions. As autism continues to be a prevalent disorder with more cases emerging everyday, suggesting the use of aluminum in vaccines could be a part of its cause is plausible. It could be hypothesized that if aluminum is forgone in vaccines and other products, autism cases have the potential to decrease.